DalsnaFinance

SandboxAQ Launches Virtual Screening Solution for GPCR Drug Discovery, Accelerated by NVIDIA BioNeMo

Markets PR Newswire By PR Newswire 23 Jun 2026 13:00 1 min read
SandboxAQ Launches Virtual Screening Solution for GPCR Drug Discovery, Accelerated by NVIDIA BioNeMo

PALO ALTO, Calif., June 23, 2026 /PRNewswire/ -- SandboxAQ today announced a new virtual screening solution that helps drug developers identify promising candidates faster and at lower cost for G protein-coupled receptors (GPCRs), one of the most valuable yet hardest-to-drug families of...

PALO ALTO, Calif., June 23, 2026 /PRNewswire/ -- SandboxAQ today announced a new virtual screening solution that helps drug developers identify promising candidates faster and at lower cost for G protein-coupled receptors (GPCRs), one of the most valuable yet hardest-to-drug families of...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.